顺序启动多组学研究以推进人类健康特征的刻画-动脉网

Sequential Launches Multi-Omic Studies to Advance Human Health Characterization

CISION 等信源发布 2025-04-02 19:00



可切换为仅中文







LONDON

伦敦

，

April 2, 2025

2025年4月2日

/PRNewswire/ -- Sequential, a leader in microbiome research, is proud to announce the launch of its Multi-Omic Studies, a groundbreaking initiative that integrates human and microbial analysis to redefine skin health research. By combining advanced genetic, metabolic, and microbiome profiling, Sequential is setting a new standard in clinical testing for personal care and pharmaceutical industries..

/PRNewswire/ -- 微生物组研究领域的领导者Sequential自豪地宣布推出其多组学研究，这是一项整合人类和微生物分析以重新定义皮肤健康研究的开创性举措。通过结合先进的基因、代谢和微生物组分析，Sequential正在为个人护理和制药行业的临床测试设立新标准。

'Our Multi-Omic approach bridges the gap between host biology and microbial interactions, offering unparalleled insights into skin health,' said Dr.

“我们的多组学方法弥合了宿主生物学与微生物相互作用之间的差距，为皮肤健康提供了无与伦比的见解，”博士说道。

Albert Dashi

阿尔伯特·达希

, Chief Science Officer at Sequential. 'By leveraging cutting-edge technologies, we empower brands to develop more precise, effective, and scientifically validated formulations.'

Sequential公司的首席科学官表示：“通过利用尖端技术，我们帮助品牌开发更精确、更有效且经过科学验证的配方。”

A Holistic Approach to Skin Health

整体皮肤健康方法

Sequential's Multi-Omic Studies provide a comprehensive view of skin health through:

Sequential的多组学研究通过以下方式提供了皮肤健康的全面视角：

Human-Centered Analysis: Includes SNP detection, metabolomics, gene expression, protein profiling, and lipid profiling to assess how the human body responds to formulations at a molecular level.

以人为中心的分析：包括SNP检测、代谢组学、基因表达、蛋白质谱和脂质谱，以评估人体在分子水平上对配方的反应。

Microbiome-Centered Analysis: Utilizes Sequential's proprietary Smart Probes™ (qPCR), 16S sequencing, ITS sequencing, shotgun metagenomics, and metatranscriptomics to evaluate microbial shifts in response to treatments.

以微生物组为中心的分析：利用Sequential专有的Smart Probes™（qPCR）、16S测序、ITS测序、宏基因组学和宏转录组学技术，评估治疗引起的微生物变化。

With over 25,000 clinical skin microbiome samples in its database, Sequential continues to drive precision innovation in microbiome research. This new initiative not only enhances product efficacy testing but also advances scientific understanding of skin health.

Sequential的数据库中拥有超过25,000份临床皮肤微生物组样本，继续推动微生物组研究的精准创新。这一新举措不仅增强了产品功效测试，还促进了对皮肤健康科学理解的进步。

Sequential invites brands and researchers to collaborate in shaping the future of personalized skin care and microbiome science.

Sequential邀请品牌和研究人员合作，共同塑造个性化护肤和微生物组科学的未来。

About Sequential

关于顺序quential

Sequential is a global leader in the skin microbiome field, a team of PhD experts in testing products and their effect on the human microbiome (skin, scalp, oral, vulva). An Innovate UK- and Enterprise Singapore-backed company, with labs in

Sequential是皮肤微生物组领域的全球领导者，拥有一个由博士专家组成的团队，负责测试产品及其对人体微生物组（皮肤、头皮、口腔、外阴）的影响。这是一家得到英国创新署（Innovate UK）和新加坡企业发展局（Enterprise Singapore）支持的公司，在多地设有实验室。

London

伦敦

，

New York City

纽约市

and

和

Singapore

新加坡

. Awarded the title 'Most Significant' Testing Solution in the Industry - (C&T, 2022). To date, Sequential has amassed over 25,000 human skin microbiome samples and corresponding formulations tested in vivo on the skin. With this vast genomic dataset, Sequential are figuring out optimal formulations that could potentially alleviate skin conditions, for example – acne, atopic dermatitis and rosacea.

被评为行业内“最具影响力”的测试解决方案（C&T，2022）。迄今为止，Sequential已经收集了超过25,000个人类皮肤微生物组样本，并在皮肤上进行了相应的配方活体测试。通过这一庞大的基因组数据集，Sequential正在找出可能缓解皮肤状况的优化配方，例如痤疮、特应性皮炎和玫瑰痤疮。

They have been supported by. They have raised .

他们得到了支持。他们已经筹集了。

$5,000,000 USD

5,000,000美元

to date from Innovate UK, Enterprise SG, A*STAR (Genome Institute of

截至目前，已从 Innovate UK、Enterprise SG、A*STAR（基因组研究所）

Singapore

新加坡

), SOSV, Corundum Systems Biology and other leading organisations.

），SOSV、Corundum Systems Biology 以及其他领先组织。

Logo: